1398066-06-2

1398066-06-2 structure

Name: 2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5
Chemical Name: 4-(4-Chlorophenyl)-2-(2H5)phenyl-2-(1H-1,2,4-triazol-1-ylmethyl)butanenitrile
CAS Number: 1398066-06-2
Molecular Formula: C₁₉H₁₂D₅ClN₄
Molecular Weight: 341.849
Catalog: Research Areas Others
Create Date: 2018-04-09 13:34:30
Modify Date: 2024-09-18 11:05:46
2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5 is the deuterium labeled 2-((1H-1,2,4-triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile[1].

Name	4-(4-Chlorophenyl)-2-(2H5)phenyl-2-(1H-1,2,4-triazol-1-ylmethyl)butanenitrile
Synonyms	1H-1,2,4-Triazole-1-propanenitrile, α-[2-(4-chlorophenyl)ethyl]-α-(phenyl-d)- 4-(4-Chlorophenyl)-2-(H)phenyl-2-(1H-1,2,4-triazol-1-ylmethyl)butanenitrile

Description	2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5 is the deuterium labeled 2-((1H-1,2,4-triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.